Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2023-05-11
2025-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease
NCT04299308
Effects of Aging and Aerobic Exercise Training on Brain Glucose Metabolism
NCT01738568
Alzheimer's Prevention Through Exercise
NCT02000583
Exercise and Brain Vascular Function
NCT03272061
Exercise in Older Adults at Risk for Type 2 Diabetes
NCT05229705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rest
Individuals will rest for about 1 hour in the seated position to mimic time exercising.
No interventions assigned to this group
Exercise
Individuals will exercise for at medium to hard intensity for 1 hour.
Exercise
Exercise will be walking/jogging at a medium to hard intensity for 1 hour.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Exercise will be walking/jogging at a medium to hard intensity for 1 hour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has a body mass index \>/=25 and \</=45 kg/m2.
* Physical Activity (\<150 min of moderate/high intensity exercise per week)
Exclusion Criteria
* Subjects who are smokers or who have quit smoking \<1 years ago
* Subjects with abnormal estimated glomerular filtration rate (eGFR).
* Hypertriglyceridemic (\>400 mg/dl) and hypercholesterolemic (\>260 mg/dl) subjects
* Hypertensive (\>160/100 mmHg)
* Subjects with a history of significant metabolic, cardiac, congestive heart failure, cerebrovascular, hematological, pulmonary, gastrointestinal, liver, renal, or endocrine disease or cancer that in the investigator's opinion would interfere with or alter the outcome measures or impact subject safety.
* Pregnant (as evidenced by positive urine pregnancy test) or nursing women
* Subjects with contraindications to participation in an exercise
* Current Pregnancy
* Currently taking active weight suppression medication (e.g. phentermine, orlistat, lorcaserin, naltrexone-bupropion in combination, liraglutide, benzphetamine, diethylpropion, phendimetrazine)
* Subjects currently taking medications that affect heart rate and rhythm (i.e. Ca++ channel blockers, nitrates, alpha- or beta-blockers).
* Known contraindications for MRI imaging
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steven K Malin, PhD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven K Malin, PhD
Role: PRINCIPAL_INVESTIGATOR
Rutgers University - New Brunswick
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Food, Nutrition, and Health
New Brunswick, New Jersey, United States
Robert Wood Johnson University Hospital Clinical Research Center
New Brunswick, New Jersey, United States
Rutgers University Loree Gymnasium
New Brunswick, New Jersey, United States
Center for Advanced Human Brain Imaging Research
Piscataway, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro2022001842
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.